The global external defibrillators market has witnessed significant growth, with its estimated valuation reaching USD 3.51 billion in 2023. This market is expected to expand at a robust compound annual growth rate (CAGR) of 9.7% from 2024 to 2030. Several key factors are contributing to this upward trajectory, including advancements in technology, proactive government measures promoting the installation of Automated External Defibrillators (AEDs) in public spaces, rising cases of sudden cardiac arrest, and strategic initiatives by major industry players.

Public access to AEDs has played a pivotal role in improving survival rates for sudden cardiac arrests. In March 2021, the American College of Cardiology Foundation emphasized the critical impact of AED availability on increasing survival chances. Additionally, the growing prevalence of heart-related conditions has further strengthened the demand for AEDs, particularly for at-home usage. These devices offer promising solutions to mitigate the risks associated with cardiac emergencies in varied population segments.

The COVID-19 pandemic served as an unexpected catalyst for heightened demand in the external defibrillators market. Despite logistical challenges and disruptions in supply chains due to movement restrictions, manufacturers experienced a surge in sales. Nihon Kohden, for instance, reported substantial international sales growth in 2020, notably in the U.S. and Latin America. Countries like Mexico and Colombia witnessed a remarkable 200% increase in sales of Nihon Kohden’s patient monitors, defibrillators, and ventilators. Similarly, Philips secured FDA clearance in June 2020 for its HeartStart FRx and HeartStart FR3 AEDs, which feature innovative capabilities aimed at enhancing emergency cardiac care for both healthcare professionals and general users in public settings.

Government policies and regulatory actions worldwide are expected to further accelerate market growth. Notably, Italy’s Social Affairs Commission of the Chamber approved a legislative proposal concerning AED implementation in July 2021. The plan allocates around 10 million EUR (approximately USD 11.36 million) over five years to expand public access to defibrillators. Likewise, Australia’s SA Ambulance Service (SAAS) strongly advocates for early defibrillator use to boost survival rates. While manual defibrillators are designated for trained professionals, both semiautomatic and automatic AEDs are encouraged for broader usage due to their ease of operation, especially in clinics and allied healthcare settings

.

Detailed Segmentation:

Product Insights

The manual external defibrillators segment led the market in 2023, holding the largest revenue share of more than 39.58%. This dominance is primarily driven by continuous technological advancements that have significantly improved the efficiency and adaptability of manual external defibrillators. These innovations have enhanced precision in cardiac emergency interventions, making them a preferred choice for medical professionals in specialized healthcare settings.

End-use Insights

From an end-use perspective, the hospital segment accounted for the largest revenue share of over 26.01% in 2023. Hospitals serve a high volume of patients, necessitating the widespread adoption of external defibrillators for effective cardiac emergency response. The increasing prevalence of heart-related disorders has further reinforced the demand for these devices, particularly in hospital cardiology units where defibrillators are crucial for managing patients with severe cardiac complications. Additionally, major industry players continue to implement strategies aimed at expanding product adoption in healthcare facilities, further strengthening the hospital segment's market position.

Regional Insights

In 2023, North America dominated the market, securing a substantial revenue share of more than 42.93%. Several factors contributed to this regional leadership, including the strong presence of key market players, favorable government regulations supporting the widespread deployment of public-access AEDs, and a high rate of adoption in healthcare institutions. Regulatory initiatives promoting AED availability, coupled with heightened awareness about cardiac health, have positioned North America as a key market driver in the global external defibrillators industry.

Key External Defibrillators Companies:

• Koninklijke Philips N.V.
• Stryker
• ZOLL Medical Corporation
• Nihon Kohden Corporation
• Progetti Srl
• Schiller AG
• MS Westfalia GmbH
• AMI Italia
• Bexen Cardio
• Silverline Meditech Pvt. Ltd.
• Mediana Co., Ltd.
• Shenzhen Mindray Bio-Medical Electronics
• CU Medical
• BPL Medical Technologies
• Corpuls

Order a free sample PDF of the Market Intelligence Study, published by Grand View Research.